Literature DB >> 28179078

Serum resistance and phase variation of a nasopharyngeal non-typeable Haemophilus influenzae isolate.

Sabine Lichtenegger1, Isabelle Bina2, Sanel Durakovic2, Philippe Glaser3, Sarah Tutz2, Stefan Schild4, Joachim Reidl5.   

Abstract

Haemophilus influenzae harbours a complex array of factors to resist human complement attack. As non-typeable H. influenzae (NTHi) strains do not possess a capsule, their serum resistance mainly depends on other mechanisms including LOS decoration. In this report, we describe the identification of a highly serum resistant, nasopharyngeal isolate (NTHi23) by screening a collection of 77 clinical isolates. For NTHi23, we defined the MLST sequence type 1133, which matches the profile of a previously published invasive NTHi isolate. A detailed genetic analysis revealed that NTHi23 shares several complement evading mechanisms with invasive disease isolates. These mechanisms include the functional expression of a retrograde phospholipid trafficking system and the presumable decoration of the LOS structure with sialic acid. By screening the NTHi23 population for spontaneous decreased serum resistance, we identified a clone, which was about 103-fold more sensitive to complement-mediated killing. Genome-wide analysis of this isolate revealed a phase variation in the N'-terminal region of lpsA, leading to a truncated version of the glycosyltransferase (LpsA). We further showed that a NTHi23 lpsA mutant exhibits a decreased invasion rate into human alveolar basal epithelial cells. Since only a small proportion of the NTHi23 population expressed the serum sensitive phenotype, resulting from lpsA phase-off, we conclude that the nasopharyngeal environment selected for a population expressing the intact and functional glycosyltransferase.
Copyright © 2017 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Haemophilus influenzae; Phase variation; Serum resistance; lpsA

Mesh:

Substances:

Year:  2017        PMID: 28179078     DOI: 10.1016/j.ijmm.2017.01.005

Source DB:  PubMed          Journal:  Int J Med Microbiol        ISSN: 1438-4221            Impact factor:   3.473


  5 in total

1.  Epidemiological analysis and rapid detection by one-step multiplex PCR assay of Haemophilus influenzae in children with respiratory tract infections in Zhejiang Province, China.

Authors:  Xingli Fan; Xiaoxiang Liu; Lei Ji; Damin Cai; Jinqin Jiang; Jingjing Zhu; Aihua Sun; Jie Yan
Journal:  BMC Infect Dis       Date:  2018-08-22       Impact factor: 3.090

2.  The Alternative Sigma Factor RpoE2 Is Involved in the Stress Response to Hypochlorite and in vivo Survival of Haemophilus influenzae.

Authors:  Marufa Nasreen; Aidan Fletcher; Jennifer Hosmer; Qifeng Zhong; Ama-Tawiah Essilfie; Alastair G McEwan; Ulrike Kappler
Journal:  Front Microbiol       Date:  2021-02-12       Impact factor: 5.640

3.  Access to highly specialized growth substrates and production of epithelial immunomodulatory metabolites determine survival of Haemophilus influenzae in human airway epithelial cells.

Authors:  Jennifer Hosmer; Marufa Nasreen; Rabeb Dhouib; Ama-Tawiah Essilfie; Horst Joachim Schirra; Anna Henningham; Emmanuelle Fantino; Peter Sly; Alastair G McEwan; Ulrike Kappler
Journal:  PLoS Pathog       Date:  2022-01-27       Impact factor: 6.823

4.  Development of flow cytometric opsonophagocytosis and antibody-mediated complement deposition assays for non-typeable Haemophilus influenzae.

Authors:  Stephen R Thomas; Stephanie Leung; Katy Knox; Tom M A Wilkinson; Karl J Staples; Pascal Lestrate; Dominique Wauters; Andrew Gorringe; Stephen C Taylor
Journal:  BMC Microbiol       Date:  2018-10-29       Impact factor: 3.605

5.  Non-Typeable Haemophilus influenzae Invade Choroid Plexus Epithelial Cells in a Polar Fashion.

Authors:  Christian Wegele; Carolin Stump-Guthier; Selina Moroniak; Christel Weiss; Manfred Rohde; Hiroshi Ishikawa; Horst Schroten; Christian Schwerk; Michael Karremann; Julia Borkowski
Journal:  Int J Mol Sci       Date:  2020-08-10       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.